Jeffrey N. Simmons - 22 Feb 2022 Form 4 Insider Report for Elanco Animal Health Inc (ELAN)

Role
President, CEO and Director, Director
Signature
/s/ Collin G. Smyser, as Attorney-in-Fact for Jeffrey N. Simmons
Issuer symbol
ELAN
Transactions as of
22 Feb 2022
Net transactions value
-$2,414,789
Form type
4
Filing time
24 Feb 2022, 15:40:29 UTC
Previous filing
22 Oct 2021
Next filing
03 Mar 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ELAN Common Stock Award $0 +229,655 +42% $0.000000 782,418 22 Feb 2022 Direct F1
transaction ELAN Common Stock Tax liability $2,414,789 -92,948 -12% $25.98 689,470 22 Feb 2022 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Vesting of performance-based restricted stock units granted under the 2018 Elanco Stock Plan.
F2 Represents shares tendered to the Company to cover the Reporting Person's tax liability upon vesting of performance-based restricted stock units granted under the 2018 Elanco Stock Plan.

Remarks:

EXHIBIT LIST - Exhibit 24 - Power of Attorney